nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS1—kidney cancer	0.391	0.636	CbGaD
Phenylbutazone—PTGS2—kidney cancer	0.224	0.364	CbGaD
Phenylbutazone—CYP3A4—Everolimus—kidney cancer	0.0507	0.208	CbGbCtD
Phenylbutazone—CYP3A4—Temsirolimus—kidney cancer	0.0343	0.141	CbGbCtD
Phenylbutazone—CYP2C9—Capecitabine—kidney cancer	0.0323	0.132	CbGbCtD
Phenylbutazone—CYP2C9—Paclitaxel—kidney cancer	0.0202	0.083	CbGbCtD
Phenylbutazone—CYP3A4—Pazopanib—kidney cancer	0.018	0.0739	CbGbCtD
Phenylbutazone—CYP2C9—Sorafenib—kidney cancer	0.018	0.0737	CbGbCtD
Phenylbutazone—CYP3A4—Erlotinib—kidney cancer	0.0128	0.0527	CbGbCtD
Phenylbutazone—CYP3A4—Paclitaxel—kidney cancer	0.0118	0.0482	CbGbCtD
Phenylbutazone—CYP3A4—Sorafenib—kidney cancer	0.0104	0.0428	CbGbCtD
Phenylbutazone—CYP3A4—Vinblastine—kidney cancer	0.0103	0.0423	CbGbCtD
Phenylbutazone—CYP3A4—Vincristine—kidney cancer	0.0101	0.0416	CbGbCtD
Phenylbutazone—CYP3A4—Sunitinib—kidney cancer	0.00846	0.0347	CbGbCtD
Phenylbutazone—SLC22A8—nephron—kidney cancer	0.00714	0.145	CbGeAlD
Phenylbutazone—CYP3A4—Doxorubicin—kidney cancer	0.00634	0.026	CbGbCtD
Phenylbutazone—SLC22A8—urine—kidney cancer	0.00573	0.117	CbGeAlD
Phenylbutazone—PTGS2—nephron—kidney cancer	0.00405	0.0824	CbGeAlD
Phenylbutazone—CYP2C9—urine—kidney cancer	0.00373	0.0757	CbGeAlD
Phenylbutazone—CYP3A4—urine—kidney cancer	0.00284	0.0578	CbGeAlD
Phenylbutazone—SLC22A11—nephron tubule—kidney cancer	0.00273	0.0556	CbGeAlD
Phenylbutazone—SLC22A6—nephron tubule—kidney cancer	0.00258	0.0524	CbGeAlD
Phenylbutazone—SLC22A11—renal system—kidney cancer	0.00249	0.0505	CbGeAlD
Phenylbutazone—SLC22A11—kidney—kidney cancer	0.0024	0.0489	CbGeAlD
Phenylbutazone—SLC22A11—cortex of kidney—kidney cancer	0.00234	0.0476	CbGeAlD
Phenylbutazone—SLC22A6—cortex of kidney—kidney cancer	0.00221	0.0448	CbGeAlD
Phenylbutazone—SLC22A8—nephron tubule—kidney cancer	0.00154	0.0314	CbGeAlD
Phenylbutazone—SLC22A8—renal system—kidney cancer	0.0014	0.0285	CbGeAlD
Phenylbutazone—SLC22A8—kidney—kidney cancer	0.00136	0.0276	CbGeAlD
Phenylbutazone—SLC22A8—cortex of kidney—kidney cancer	0.00132	0.0268	CbGeAlD
Phenylbutazone—PTGS1—renal system—kidney cancer	0.000832	0.0169	CbGeAlD
Phenylbutazone—PTGS1—kidney—kidney cancer	0.000804	0.0164	CbGeAlD
Phenylbutazone—PTGS2—renal system—kidney cancer	0.000795	0.0162	CbGeAlD
Phenylbutazone—PTGS2—kidney—kidney cancer	0.000769	0.0156	CbGeAlD
Phenylbutazone—PTGS1—cardiac atrium—kidney cancer	0.000745	0.0152	CbGeAlD
Phenylbutazone—Trimethaphan—BCHE—kidney cancer	0.000743	0.264	CrCbGaD
Phenylbutazone—CYP3A4—renal system—kidney cancer	0.000695	0.0141	CbGeAlD
Phenylbutazone—CYP3A4—kidney—kidney cancer	0.000672	0.0137	CbGeAlD
Phenylbutazone—Oxaprozin—PTGS1—kidney cancer	0.000552	0.196	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS2—kidney cancer	0.000316	0.112	CrCbGaD
Phenylbutazone—Protriptyline—ABCB1—kidney cancer	0.000272	0.0967	CrCbGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—kidney cancer	0.000249	0.0884	CrCbGaD
Phenylbutazone—Diphenhydramine—PTGS1—kidney cancer	0.000199	0.0705	CrCbGaD
Phenylbutazone—Fentanyl—ABCB1—kidney cancer	0.000136	0.0482	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—kidney cancer	0.000135	0.048	CrCbGaD
Phenylbutazone—Phenytoin—ABCB1—kidney cancer	0.000123	0.0437	CrCbGaD
Phenylbutazone—Methadone—ABCB1—kidney cancer	9.32e-05	0.0331	CrCbGaD
Phenylbutazone—PTGS2—Metabolism—PDHB—kidney cancer	4.85e-05	0.000543	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—kidney cancer	4.84e-05	0.000541	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HIF1A—kidney cancer	4.83e-05	0.00054	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TSC2—kidney cancer	4.82e-05	0.000539	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.8e-05	0.000537	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GSTM1—kidney cancer	4.8e-05	0.000536	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	4.72e-05	0.000527	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.69e-05	0.000525	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.68e-05	0.000523	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APRT—kidney cancer	4.63e-05	0.000518	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—FH—kidney cancer	4.63e-05	0.000518	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	4.59e-05	0.000513	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CCBL1—kidney cancer	4.56e-05	0.00051	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP1A1—kidney cancer	4.55e-05	0.000509	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GSTM1—kidney cancer	4.53e-05	0.000507	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.53e-05	0.000506	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	4.47e-05	0.0005	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.4e-05	0.000492	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPC3—kidney cancer	4.36e-05	0.000487	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	4.3e-05	0.000481	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APC—kidney cancer	4.25e-05	0.000476	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KIT—kidney cancer	4.25e-05	0.000476	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	4.24e-05	0.000474	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA2—kidney cancer	4.24e-05	0.000474	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALAD—kidney cancer	4.13e-05	0.000462	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GPC3—kidney cancer	4.13e-05	0.000462	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.13e-05	0.000461	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.03e-05	0.000451	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.01e-05	0.000448	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BRAF—kidney cancer	4e-05	0.000447	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.98e-05	0.000445	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPAT—kidney cancer	3.96e-05	0.000442	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GLIPR1—kidney cancer	3.96e-05	0.000442	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALDH1A1—kidney cancer	3.94e-05	0.000441	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.91e-05	0.000437	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.89e-05	0.000435	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.87e-05	0.000432	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ST3GAL2—kidney cancer	3.82e-05	0.000427	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.78e-05	0.000423	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ACY1—kidney cancer	3.78e-05	0.000423	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PGK1—kidney cancer	3.78e-05	0.000422	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC5A3—kidney cancer	3.78e-05	0.000422	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.74e-05	0.000418	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LDHB—kidney cancer	3.71e-05	0.000414	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.7e-05	0.000414	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FH—kidney cancer	3.68e-05	0.000411	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APRT—kidney cancer	3.68e-05	0.000411	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.67e-05	0.00041	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.63e-05	0.000406	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.6e-05	0.000402	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PGK1—kidney cancer	3.58e-05	0.0004	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC5A3—kidney cancer	3.58e-05	0.0004	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—RAF1—kidney cancer	3.56e-05	0.000398	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LDHB—kidney cancer	3.51e-05	0.000393	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SFRP2—kidney cancer	3.51e-05	0.000393	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPC3—kidney cancer	3.46e-05	0.000387	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—POMC—kidney cancer	3.39e-05	0.000379	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA2—kidney cancer	3.37e-05	0.000376	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.36e-05	0.000376	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RAF1—kidney cancer	3.34e-05	0.000373	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB2—kidney cancer	3.3e-05	0.000369	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALAD—kidney cancer	3.28e-05	0.000367	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TCEB1—kidney cancer	3.28e-05	0.000366	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TCEB2—kidney cancer	3.28e-05	0.000366	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTOR—kidney cancer	3.26e-05	0.000364	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD4—kidney cancer	3.25e-05	0.000364	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.25e-05	0.000364	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—kidney cancer	3.23e-05	0.000361	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.22e-05	0.00036	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PDHB—kidney cancer	3.22e-05	0.000359	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA9—kidney cancer	3.21e-05	0.000359	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.21e-05	0.000359	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.21e-05	0.000359	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—POMC—kidney cancer	3.2e-05	0.000358	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.2e-05	0.000358	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.2e-05	0.000358	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.18e-05	0.000355	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.14e-05	0.000351	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.13e-05	0.00035	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.11e-05	0.000347	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.1e-05	0.000346	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1B—kidney cancer	3.06e-05	0.000342	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CCBL1—kidney cancer	3.02e-05	0.000338	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PGK1—kidney cancer	3e-05	0.000335	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC5A3—kidney cancer	3e-05	0.000335	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.99e-05	0.000334	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.95e-05	0.00033	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LDHB—kidney cancer	2.94e-05	0.000329	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—kidney cancer	2.89e-05	0.000323	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.83e-05	0.000317	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTEN—kidney cancer	2.82e-05	0.000315	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.8e-05	0.000313	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.8e-05	0.000313	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.73e-05	0.000306	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CRABP1—kidney cancer	2.73e-05	0.000305	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	2.72e-05	0.000304	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—kidney cancer	2.71e-05	0.000302	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RPL14—kidney cancer	2.66e-05	0.000298	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.65e-05	0.000296	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.62e-05	0.000293	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPAT—kidney cancer	2.62e-05	0.000293	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.59e-05	0.000289	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.57e-05	0.000288	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.56e-05	0.000286	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA9—kidney cancer	2.55e-05	0.000285	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ITPR2—kidney cancer	2.54e-05	0.000284	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.52e-05	0.000281	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACY1—kidney cancer	2.49e-05	0.000279	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.49e-05	0.000279	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FH—kidney cancer	2.44e-05	0.000272	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APRT—kidney cancer	2.44e-05	0.000272	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK3—kidney cancer	2.41e-05	0.000269	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ITPR2—kidney cancer	2.41e-05	0.000269	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.38e-05	0.000266	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.38e-05	0.000266	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTEN—kidney cancer	2.36e-05	0.000264	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—kidney cancer	2.34e-05	0.000262	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.34e-05	0.000262	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ACHE—kidney cancer	2.32e-05	0.000259	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTT1—kidney cancer	2.32e-05	0.000259	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPC3—kidney cancer	2.29e-05	0.000256	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK1—kidney cancer	2.29e-05	0.000256	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.27e-05	0.000254	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA2—kidney cancer	2.23e-05	0.000249	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SCARB1—kidney cancer	2.19e-05	0.000245	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.18e-05	0.000244	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALAD—kidney cancer	2.17e-05	0.000243	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CRABP1—kidney cancer	2.17e-05	0.000242	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—kidney cancer	2.16e-05	0.000242	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PSMD7—kidney cancer	2.13e-05	0.000238	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PDHB—kidney cancer	2.12e-05	0.000237	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.12e-05	0.000237	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—POMC—kidney cancer	2.11e-05	0.000236	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.11e-05	0.000236	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.07e-05	0.000232	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BCHE—kidney cancer	2.02e-05	0.000226	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PSMD7—kidney cancer	2.02e-05	0.000226	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ITPR2—kidney cancer	2.02e-05	0.000225	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.99e-05	0.000223	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC5A5—kidney cancer	1.99e-05	0.000223	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—kidney cancer	1.99e-05	0.000222	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.99e-05	0.000222	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PGK1—kidney cancer	1.99e-05	0.000222	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LDHB—kidney cancer	1.95e-05	0.000218	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC2A1—kidney cancer	1.92e-05	0.000215	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.87e-05	0.000209	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.86e-05	0.000208	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ACHE—kidney cancer	1.84e-05	0.000206	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTT1—kidney cancer	1.84e-05	0.000206	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC2A1—kidney cancer	1.82e-05	0.000204	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JUNB—kidney cancer	1.81e-05	0.000202	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SCARB1—kidney cancer	1.74e-05	0.000195	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPAT—kidney cancer	1.73e-05	0.000193	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.73e-05	0.000193	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTGS1—kidney cancer	1.72e-05	0.000193	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PSMD7—kidney cancer	1.69e-05	0.000189	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA9—kidney cancer	1.69e-05	0.000189	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—kidney cancer	1.66e-05	0.000186	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.65e-05	0.000185	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.63e-05	0.000182	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FH—kidney cancer	1.61e-05	0.00018	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APRT—kidney cancer	1.61e-05	0.00018	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTP1—kidney cancer	1.61e-05	0.000179	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BCHE—kidney cancer	1.6e-05	0.000179	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC5A5—kidney cancer	1.58e-05	0.000177	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC2A1—kidney cancer	1.53e-05	0.000171	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—kidney cancer	1.52e-05	0.00017	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPC3—kidney cancer	1.51e-05	0.000169	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—kidney cancer	1.48e-05	0.000165	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—kidney cancer	1.47e-05	0.000165	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA2—kidney cancer	1.47e-05	0.000164	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CRABP1—kidney cancer	1.44e-05	0.000161	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALAD—kidney cancer	1.43e-05	0.00016	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP1A1—kidney cancer	1.4e-05	0.000156	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.4e-05	0.000156	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.37e-05	0.000153	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ITPR2—kidney cancer	1.34e-05	0.000149	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PGK1—kidney cancer	1.31e-05	0.000146	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.31e-05	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.29e-05	0.000145	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LDHB—kidney cancer	1.28e-05	0.000144	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTP1—kidney cancer	1.27e-05	0.000142	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.23e-05	0.000138	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—kidney cancer	1.22e-05	0.000136	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ACHE—kidney cancer	1.22e-05	0.000136	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—kidney cancer	1.21e-05	0.000135	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIF1A—kidney cancer	1.18e-05	0.000132	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TSC2—kidney cancer	1.18e-05	0.000131	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—kidney cancer	1.17e-05	0.000131	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SCARB1—kidney cancer	1.15e-05	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.15e-05	0.000128	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS1—kidney cancer	1.14e-05	0.000128	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PSMD7—kidney cancer	1.12e-05	0.000125	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA9—kidney cancer	1.11e-05	0.000125	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1A1—kidney cancer	1.11e-05	0.000124	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BCHE—kidney cancer	1.06e-05	0.000119	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.05e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POMC—kidney cancer	1.04e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KIT—kidney cancer	1.04e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—kidney cancer	1.04e-05	0.000116	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.01e-05	0.000113	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.82e-06	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BRAF—kidney cancer	9.76e-06	0.000109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CRABP1—kidney cancer	9.47e-06	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.12e-06	0.000102	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ITPR2—kidney cancer	8.8e-06	9.84e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.56e-06	9.57e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTP1—kidney cancer	8.44e-06	9.43e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—kidney cancer	8.32e-06	9.3e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POMC—kidney cancer	8.28e-06	9.25e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RAF1—kidney cancer	8.15e-06	9.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—kidney cancer	8.06e-06	9.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACHE—kidney cancer	8.03e-06	8.98e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—kidney cancer	8.03e-06	8.98e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—kidney cancer	7.99e-06	8.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTOR—kidney cancer	7.96e-06	8.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—kidney cancer	7.94e-06	8.88e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—kidney cancer	7.75e-06	8.67e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SCARB1—kidney cancer	7.6e-06	8.5e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS1—kidney cancer	7.52e-06	8.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—kidney cancer	7.47e-06	8.35e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PSMD7—kidney cancer	7.38e-06	8.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.35e-06	8.22e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—kidney cancer	7.25e-06	8.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—kidney cancer	7.05e-06	7.88e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BCHE—kidney cancer	6.99e-06	7.82e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.91e-06	7.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—kidney cancer	6.87e-06	7.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.67e-06	7.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.04e-06	6.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK3—kidney cancer	5.87e-06	6.57e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—kidney cancer	5.76e-06	6.44e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—kidney cancer	5.71e-06	6.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK1—kidney cancer	5.59e-06	6.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTP1—kidney cancer	5.57e-06	6.22e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POMC—kidney cancer	5.48e-06	6.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—kidney cancer	5.28e-06	5.9e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—kidney cancer	5.27e-06	5.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—kidney cancer	5.12e-06	5.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—kidney cancer	5.11e-06	5.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—kidney cancer	4.85e-06	5.42e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.85e-06	5.42e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—kidney cancer	4.37e-06	4.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—kidney cancer	4.06e-06	4.54e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—kidney cancer	3.81e-06	4.26e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POMC—kidney cancer	3.61e-06	4.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—kidney cancer	2.88e-06	3.22e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.69e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—kidney cancer	2.51e-06	2.81e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.77e-06	1.98e-05	CbGpPWpGaD
